Avidity Partners Management’s Immunocore IMCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-200,000
| Closed | -$6.23M | – | 71 |
|
|
2024
Q3 | $6.23M | Hold |
200,000
| – | – | 0.32% | 64 |
|
|
2024
Q2 | $6.78M | Sell |
200,000
-86,400
| -30% | -$2.93M | 0.29% | 67 |
|
|
2024
Q1 | $18.6M | Sell |
286,400
-13,800
| -5% | -$897K | 0.6% | 50 |
|
|
2023
Q4 | $20.5M | Sell |
300,200
-48,000
| -14% | -$3.28M | 0.75% | 47 |
|
|
2023
Q3 | $18.1M | Sell |
348,200
-226,800
| -39% | -$11.8M | 0.73% | 52 |
|
|
2023
Q2 | $34.5M | Sell |
575,000
-194,800
| -25% | -$11.7M | 1.2% | 36 |
|
|
2023
Q1 | $38.1M | Sell |
769,800
-384,200
| -33% | -$19M | 1.26% | 31 |
|
|
2022
Q4 | $65.9M | Sell |
1,154,000
-925,100
| -44% | -$52.8M | 1.43% | 24 |
|
|
2022
Q3 | $97.6M | Buy |
2,079,100
+729,100
| +54% | +$34.2M | 1.98% | 16 |
|
|
2022
Q2 | $50.4M | Sell |
1,350,000
-13,800
| -1% | -$515K | 1.16% | 28 |
|
|
2022
Q1 | $40.8M | Buy |
1,363,800
+133,800
| +11% | +$4M | 0.85% | 33 |
|
|
2021
Q4 | $42.1M | Buy |
1,230,000
+134,400
| +12% | +$4.6M | 0.89% | 38 |
|
|
2021
Q3 | $40.6M | Buy |
1,095,600
+494,600
| +82% | +$18.3M | 0.9% | 36 |
|
|
2021
Q2 | $23.5M | Buy |
601,000
+51,000
| +9% | +$1.99M | 0.63% | 47 |
|
|
2021
Q1 | $23.4M | Buy |
+550,000
| New | +$23.4M | 0.65% | 51 |
|